Mulkens J, Poncin J, Arends J W, De Goeij A F
Department of Pathology, University Maastricht, The Netherlands.
J Pathol. 1998 Aug;185(4):360-5. doi: 10.1002/(SICI)1096-9896(199808)185:4<360::AID-PATH120>3.0.CO;2-O.
To date, the earliest mutations in colorectal adenomas have been found in the adenomatous polyposis coli (APC) gene, considered the 'gatekeeper' in tumourigenesis. To study the types of APC gene mutations and their relation to clinicopathological features which are associated with malignant potential, the mutation cluster region of the APC gene was analysed in a series of 32 human sporadic colorectal adenomas from 22 patients. DNA was extracted from frozen sections and two overlapping fragments which cover the mutation cluster region were amplified using the polymerase chain reaction (PCR). Mutations were screened with temperature gradient gel electrophoresis and identified by DNA sequencing. Mutations were found in 14 samples (44 per cent) from 11 patients. The changes could be characterized as point mutations (n = 7), deletions of one or more nucleotides (n = 6), and insertions (n = 1). From five patients, multiple adenoma samples were obtained and the adenomas from two of these patients showed a heterogeneous mutation pattern in the APC gene. All detected mutations are predicted to result in a truncated APC protein. Genetic alterations in the mutation cluster region of the APC gene occurred significantly more frequently in large adenomas and showed a trend towards an increase in villous adenomas and adenomas with moderate and severe dysplasia. It is concluded that an increased proportion of APC gene mutations were found in the adenomas showing clinicopathological features associated with increased proliferation but not with characteristics of malignant potential. The results suggest that in a significant proportion of adenomas, other (genetic) alterations are involved in early tumourigenesis.
迄今为止,在结直肠腺瘤中发现的最早突变存在于腺瘤性息肉病 coli(APC)基因中,该基因被认为是肿瘤发生中的“守门人”。为了研究 APC 基因突变的类型及其与具有恶性潜能的临床病理特征的关系,对来自 22 名患者的一系列 32 例人类散发性结直肠腺瘤中 APC 基因的突变簇区域进行了分析。从冰冻切片中提取 DNA,并使用聚合酶链反应(PCR)扩增覆盖突变簇区域的两个重叠片段。通过温度梯度凝胶电泳筛选突变,并通过 DNA 测序进行鉴定。在 11 名患者的 14 个样本(44%)中发现了突变。这些变化可分为点突变(n = 7)、一个或多个核苷酸的缺失(n = 6)和插入(n = 1)。从 5 名患者中获得了多个腺瘤样本,其中两名患者的腺瘤在 APC 基因中显示出异质性突变模式。所有检测到的突变预计都会导致 APC 蛋白截短。APC 基因突变簇区域的基因改变在大腺瘤中发生的频率明显更高,并且在绒毛状腺瘤以及中度和重度发育异常的腺瘤中有增加的趋势。结论是,在显示与增殖增加相关但与恶性潜能特征无关的临床病理特征的腺瘤中,发现 APC 基因突变的比例增加。结果表明,在相当一部分腺瘤中,其他(遗传)改变参与了早期肿瘤发生。